|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Sun., May. 19, 6:54 AM
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary Stock Offerings| This Slide: #21 of 25 |
Slide #21. Alexandria Real Estate Equities, Inc. — Secondary Offering
Company:
Alexandria Real Estate Equities, Inc. (NYSE:ARE)
Date announced:
5/13/2013
Shares Offered:
6,600,000
Date of Pricing:
5/14/2013
Price Per Share:
$73.50
Closed Date:
5/17/2013
Date of Over-Allotment Closing:
5/17/2013
Final Completed Deal Size:
7,590,000
Secondary Offering Details:
Alexandria Real Estate Equities, Inc. announced that it is commencing an underwritten public offering of 6,000,000 shares of common stock. BofA Merrill Lynch, Citigroup, and J.P. Morgan will act as joint book-running managers for the offering. Alexandria Real Estate Equities, Inc. expects to grant the underwriters a thirty-day option to purchase up to 900,000 additional shares. The Company intends to initially use the net proceeds from this offering to reduce the outstanding balance on its unsecured senior line of credit. The Company may then borrow from time to time under its unsecured senior line of credit to fund the selective development or redevelopment of life science properties, to fund property acquisitions, to repay other debt, or for general working capital and other corporate purposes.--updated 5/17 - Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced today that it completed the sale of its previously announced underwritten public offering of shares of common stock. The Company sold a total of 7,590,000 shares of common stock at a price of $73.50 per share, including 990,000 shares issued pursuant to the exercise in full of the underwriters' option to purchase additional shares. The net proceeds of the sale were approximately $535.5 million, after payment of underwriting discounts and commissions.
Alexandria Real Estate Equities is a self-administered and self-managed real estate investment trust focused principally on owning, operating, developing, redeveloping, and acquiring real estate for the life science industry. Co.'s client tenants span the life science industry, including academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As of Dec. 31 2012 Co. had 178 properties aggregating approximately 17.1 million rentable sq. ft.
Preferred: ARE.PRE
Open the ARE Page at The Online Investor »
|
|||||||||||||||||||||
Open the ARE Page at The Online Investor (in a new window) »
|
Trade ARE Now: |
Avg. Broker Rec.
|
Buy (3.00 out of 4) 53rd percentile
(ranked higher than approx. 53% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2013, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.